Exploring innovative CRISPR applications in therapeutic gene editing and advancing the frontiers of genetic medicine
Our research focuses on developing cutting-edge gene editing technologies for therapeutic applications. Using CRISPR-Cas9 and related systems, we're working to create more precise and efficient methods for genetic modification with potential applications in treating genetic disorders.
Developed novel methods to significantly reduce off-target effects in CRISPR-based gene editing, achieving up to 90% reduction in unintended modifications.
Achieved breakthrough success rates in gene modification through optimized delivery systems, increasing successful edits by 75% compared to conventional methods.
Identified promising new therapeutic targets for genetic disorders, opening pathways for treating previously challenging conditions.
Nature Biotechnology, 2025
Read Full PaperCell Research, 2024
Read Full Paper